Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-12-29
Original SEC Filing: Click here

---

Webplus: SVA/20171229/6-K/2_EX-99.1/000.htm SEC Original: tv482293_ex99-1.htm
Sinovac Biotech Receives Positive Decision on its Hepatitis A Vaccine from World Health Organization BEIJING, Dec. 22, 2017 /PRNewswire/ — Sinovac Biotech Ltd. (Nasdaq: SVA) (the “Company” or “Sinovac”), a leading provider of biopharmaceutical products in China, announced today that it has received a positive decision from the World Health Organization (“WHO”) on the acceptability, in principle, of its Healive,

---

---

Webplus: SVA/20171229/6-K/3_EX-99.2/000.htm SEC Original: tv482293_ex99-2.htm
Sinovac Schedules 2017 Annual Meeting of Shareholders BEIJING, December. 29, 2017 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it will hold its 2017 Annual Meeting of Shareholders on Tuesday, February 6, 2018 at 9:00 a.m. Beijing Time. The meeting will be held at No. 39 Shangdi Xi Road, Haidian

---

---

Webplus: SVA/20171229/6-K/1/000.htm SEC Original: tv482293_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2017-12-29CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD, HAIDIAN DISTRICT
BEIJING 100085